ACEi reduces hypertension-induced hyperinflammation in COVID-19.

2021 
Antihypertensive therapy, particularly with the use of an angiotensin-converting enzyme inhibitor, improves outcomes in patients with hypertension and SARS-CoV-2 infection, who are susceptible to hyperinflammation and severe outcomes with COVID-19.
    • Correction
    • Source
    • Cite
    • Save
    2
    References
    0
    Citations
    NaN
    KQI
    []